Literature DB >> 31347388

DNA co-methylation analysis of lincRNAs across nine cancer types reveals novel potential epigenetic biomarkers in cancer.

Yunzhen Wei1,2, Siyao Dong1, Yanjiao Zhu1, Yichuan Zhao1, Cheng Wu1, Yinling Zhu1, Kun Li1, Yan Xu1.   

Abstract

Aim: The potential functions and prognostic value of lincRNAs with co-methylation events are explored in 9 cancer types. Materials & methods: Here, we evaluated the co-methylation events in promoter and gene-body regions between two lincRNAs across 9 cancer types by constructing a systematic biological framework.
Results: The co-methylation events in both promoter and gene-body regions tended to be highly cancer specific. Patient samples could be separated by tumor and normal types according to the eigengenes of universal co-methylation clusters. Functional enrichment results revealed the lincRNAs that brought promoter and gene-body co-methylation events that affected cancer progress through participating in different pathways and could serve as potential prognostic biomarkers.
Conclusion: The study provides new insight into the epigenetic regulation in cancer and leads to a potential new direction for epigenetic biomarker discovery.

Entities:  

Keywords:  co-methylation; lincRNAs; molecular signature; pan-cancer analysis

Mesh:

Substances:

Year:  2019        PMID: 31347388     DOI: 10.2217/epi-2018-0138

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  3 in total

1.  Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers.

Authors:  Ning Zhao; Maozu Guo; Chunlong Zhang; Chunyu Wang; Kuanquan Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-27

2.  ncFANs v2.0: an integrative platform for functional annotation of non-coding RNAs.

Authors:  Yuwei Zhang; Dechao Bu; Peipei Huo; Zhihao Wang; Hao Rong; Yanguo Li; Jingjia Liu; Meng Ye; Yang Wu; Zheng Jiang; Qi Liao; Yi Zhao
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

3.  Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types.

Authors:  Yunzhen Wei; Limeng Zhou; Yingzhang Huang; Dianjing Guo
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.